Upcoming Webinar :Register now for 'ULIP as an investment during economic recovery' powered by Bajaj Allianz

Unichem Laboratories Rises 2% On USFDA Approval

The company has received ANDA approval for its Allopurinol Tablets

Mar 13, 2019 / 03:21 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Share price of Unichem Laboratories rose 2.6 percent intraday on after the company received USFDA approval for Allopurinol tablets.

The company has received ANDA approval for its Allopurinol Tablets, USP 100 mg and 300 mg from the United States Food and Drug Administration (USFDA) to market a generic version of ZYLOPRIM (allopurinol) tablet, company said in a release.

The product will be commercialized from company's Ghaziabad plant.

At 1500 hours, Unichem Laboratories was quoting at Rs 206.15, up Rs 3.75, or 1.85 percent on the BSE.
Moneycontrol News
first published: Mar 13, 2019 03:21 pm

stay updated

Get Daily News on your Browser
Sections